Greenway Greenhouse Cannabis Corp. Reports Strong Q2 Financials and Strategic Expansion

Greenway Greenhouse Cannabis Corp. ( (TSE:GWAY) ) has provided an update.

Greenway Greenhouse Cannabis Corporation reported significant financial improvements in its second quarter of fiscal 2026, with a 60% increase in average net sales price per gram and a 28% reduction in cash cost per gram. The company achieved a gross profit of $827,178, marking a substantial turnaround from a previous gross loss, and improved its gross margin to 40%. The company also entered a supply agreement with 4C LABS in the UK, indicating strategic international expansion. These developments underscore Greenway’s operational efficiency and market positioning, setting a strong foundation for future growth and shareholder value.

Spark’s Take on TSE:GWAY Stock

According to Spark, TipRanks’ AI Analyst, TSE:GWAY is a Neutral.

The overall score reflects significant revenue growth and strategic corporate actions but is weighed down by financial strain and technical bearish trends. The financial performance remains a key concern with high leverage and cash flow issues, while technical indicators suggest caution. Positive corporate events offer potential upside if financial weaknesses are addressed.

To see Spark’s full report on TSE:GWAY stock, click here.

More about Greenway Greenhouse Cannabis Corp.

Greenway Greenhouse Cannabis Corporation is a cultivator of high-quality greenhouse cannabis primarily serving the Canadian market. The company focuses on producing cannabis for both recreational and medical use, with recent expansion efforts into international markets through strategic supply agreements.

Average Trading Volume: 15,613

Technical Sentiment Signal: Sell

Current Market Cap: C$26.45M

For detailed information about GWAY stock, go to TipRanks’ Stock Analysis page.